No Data
No Data
No Data
No Data
No Data
Recursion Pharmaceuticals(RXRX.US) Director Sells US$90,963.59 in Common Stock
$Recursion Pharmaceuticals(RXRX.US)$ Director Borgeson Blake sold 11,447 shares of common stock on Apr 30, 2024 at an average price of $7.9465 for a total value of $90,963.59.Source: Announcement What
Futu News16minutes ago
Form 144 | Recursion Pharmaceuticals(RXRX.US) Officer Proposes to Sell 423.5K in Common Stocks
SEC FILLINGS DISCLOSED/ May 2, $Recursion Pharmaceuticals(RXRX.US)$ Officer Gibson Christopher intends to sell 50,000 shares of its common stock on May 2, with a total market value of approximately $4
Futu NewsMay 2 22:49
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide business updates and
GlobeNewswireMay 2 20:00
Form 144 | Recursion Pharmaceuticals(RXRX.US) Officer Proposes to Sell 386.5K in Common Stocks
SEC FILLINGS DISCLOSED/ May 1, $Recursion Pharmaceuticals(RXRX.US)$ Officer Gibson Christopher intends to sell 50,000 shares of its common stock on May 1, with a total market value of approximately $3
Futu NewsMay 2 00:55
Recursion to Participate in Upcoming Investor Conferences
SALT LAKE CITY, May 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following
GlobeNewswireMay 1 20:01
Recursion Pharmaceuticals(RXRX.US) Officer Sells US$23,020.5 in Common Stock
$Recursion Pharmaceuticals(RXRX.US)$ Officer Marriott Tina sold 3,000 shares of common stock on Apr 25, 2024 at an average price of $7.6735 for a total value of $23,020.5.Source: Announcement What is
Futu NewsApr 30 07:23
No Data
No Data